SCHEMBL18514083

SCHEMBL18514083

CCc1cc(F)c(OCc2ccccc2CC(=O)OC)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 1/20 0.38
▸ MAOB P27338 2/20 0.38
▸ PARP10 Q53GL7 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ PARP15 Q460N3 1/20 0.37
▸ PARP14 Q460N5 1/20 0.37
▸ PPARG P37231 1/20 0.36
▸ PPARD Q03181 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ MCL1 Q07820 1/20 0.36
▸ CD274 Q9NZQ7 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ PTGDR2 Q9Y5Y4 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ SGMS2 Q8NHU3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18749540 0.91 PARP10 (0.39) RORCMAOBPARP10L3MBTL1ALDH1A1
SCHEMBL18514413 0.89 PTGDR2 (0.40) MAOBALDH1A1PPARGPPARDPPARA
SCHEMBL18514101 0.88 SLC22A12 (0.37) RORCL3MBTL1ALDH1A1MAPK1MRGPRX4
SCHEMBL18514089 0.87 SLC22A12 (0.41) RORCL3MBTL1ALDH1A1MAPK1PPARG
SCHEMBL18514108 0.87 SMN1; SMN2 (0.38) RORCL3MBTL1ALDH1A1MRGPRX4LMNA
SCHEMBL18515550 0.87 MCL1 (0.40) MAOBL3MBTL1ALDH1A1MAPK1MRGPRX4
SCHEMBL18514100 0.87 MRGPRX4 (0.35) RORCL3MBTL1ALDH1A1MAPK1MRGPRX4
SCHEMBL18760829 0.85 HDAC8 (0.42) MAOBALDH1A1MAPK1MRGPRX4CD274
SCHEMBL18514079 0.85 SMN1; SMN2 (0.38) PARP10L3MBTL1ALDH1A1MAPK1PARP14
SCHEMBL18514109 0.84 SMN1; SMN2 (0.43) ALDH1A1MRGPRX4LMNAFFAR4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 — — US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
EP-3130584-A1 AROMATIC COMPOUND AND USES THEREOF Sumitomo Chemical Company Limited (JP) 2017-02-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 RORC 1372/4885MAOB 624/4885PARP10 4104/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 RORC 1879/4885MAOB 326/4885PARP10 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback